Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IBIO stock hub

iBio, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IBIOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

61.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IBIO

In the news

Latest news · IBIO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-70.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-41

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IBIO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001420720
Company name	iBio, Inc.
Country	United States
Country code	US
Cusip	451033203
Employees	20
Employees Change	4%
Employees Change Percent	25
Enterprise value	$11.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US4510337086
Last refreshed	2026-05-10
Market cap	$61.8M
Market cap category	Micro-Cap
Price	$1.71
Price currency	USD
Rev Per Employee	15,000x
Sector	Healthcare
Sic	2834
Symbol	IBIO
Website	https://ibioinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-40.02%
EV/Sales	38.52x
FCF yield	-31.05%
P/B ratio	0.91x
P/S ratio	206.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$300,000
Gross Profit Growth	-20%
Gross Profit Growth3 Y	-44.97%
Gross Profit Growth5 Y	-25.53%
Net Income	$-24.7M
Net Income Growth Years	2%
Pretax Margin	-8,245.67%
Profit Per Employee	$-1.2M
ROA	-36.99
Roa5y	-26.24
ROCE	-43.55
ROE	-70.22
Roe5y	-64.48
ROIC	-41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-53.28%
Cagr15y	-44.93%
Cagr1y	101.46%
Cagr3y	-57.18%
Cagr5y	-70.8%
EPS Growth Quarters	2
EPS Growth Years	3
Revenue Growth	-20x
Revenue Growth Years	1x
Revenue Growth3 Y	-44.97x
Revenue Growth5 Y	-33.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$64.4M
Cash	$52.7M
Current Assets	$53.4M
Current Liabilities	$5.9M
Debt	$2.5M
Debt Equity	$0.04
Equity	$56.6M
Interest Coverage	-145.6
Liabilities	$7.8M
Long Term Assets	$11M
Long Term Liabilities	$1.9M
Net Cash	$50.2M
Net Cash By Market Cap	$81.3
Net Cash Growth	2,121.4%
Net Debt Equity	$-0.89
Tangible Book Value	$52.2M
Tangible Book Value Per Share	$1.74
WACC	10.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.04
Net Working Capital	$-4.7M
Quick ratio	8.93
Working Capital	$47.5M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-114.82%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.95%
1Y total return	101.37%
200-day SMA	1.59
3Y total return	-92.16%
50-day SMA	2.09
50-day SMA vs 200-day SMA	50over200
5Y total return	-99.79%
All Time High	30,300
All Time High Change	-99.99%
All Time High Date	2011-01-18
All Time Low	0.56
All Time Low Change	207.44%
All Time Low Date	2025-08-08
ATR	0.15
Beta	1.24
Beta1y	2.48
Beta2y	1.31
Ch YTD	-11.4
High	1.75
High52	3.82
High52 Date	2025-12-10
High52ch	-55.24%
Low	1.59
Low52	0.56
Low52 Date	2025-08-08
Low52ch	207.44%
Ma50ch	-18.18%
Premarket Change Percent	4.27
Premarket Price	$1.71
Premarket Volume	5,569
Price vs 200-day SMA	7.89%
RSI	42.97
RSI Monthly	37.31
RSI Weekly	46.83
Sharpe ratio	1.12x
Sortino ratio	2.09
Total Return	-114.82%
Tr YTD	-11.4
Tr15y	-99.99%
Tr1m	-18.96%
Tr1w	7.55%
Tr3m	-29.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.06
Earnings Revenue Estimate	36,000x
Operating Income	$-25.5M
Operating margin	-8,491
Price target	$4.75
Price Target Change	$178
Price Target Change Top	$192

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28,607,341%
Float Percent	79.15%
Net Borrowing	-1,133,000
Shares Insiders	2.36%
Shares Institutions	30.02%
Shares Out	36,143,561
Shares Qo Q	5.03%
Shares Yo Y	114.82%
Short Float	12.73%
Short Ratio	3.92
Short Shares	10.07

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-20.4M
Average Volume	1,052,258.5x
Bv Per Share	1.88
CAPEX	$-563,000
Ch10y	-99.95
Ch15y	-99.99
Ch1m	-18.96
Ch1w	7.55
Ch1y	101.4
Ch3m	-29.34
Ch3y	-92.16
Ch5y	-99.79
Ch6m	29.55
Change	4.27%
Change From Open	4.27
Close	1.64
Days Gap	0
Depreciation Amortization	729,000
Dollar Volume	3,138,530.6
Earnings Date	2026-05-14
Earnings Time	bmo
EBIT	$-25.5M
EBITDA	$-24.7M
EPS	$-1.53
F Score	2
FCF	$-19.2M
FCF EV Yield	-166.03x
FCF Per Share	$-0.53
Financing CF	64,733,000
Fiscal Year End	June
Founded	2,008
Investing CF	-24,445,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-10
Last Report Date	2025-12-31
Last Split Date	2023-11-29
Last Split Type	Reverse
Last10k Filing Date	2025-09-05
Ma150	1.86
Ma150ch	-7.87%
Ma20	1.83
Ma20ch	-6.3%
Net CF	21,662,000
Next Earnings Date	2026-05-22
Open	1.64
Optionable	No
Position In Range	75
Post Close	1.71
Postmarket Change Percent	1.17
Postmarket Price	$1.73
Ppne	5,311,000
Pre Close	1.64
Price Date	2026-05-08
Ptbv Ratio	1.18
Relative Volume	1.74x
Revenue	300,000x
SBC By Revenue	405.33x
Share Based Comp	1,216,000
Tr6m	29.55%
Us State	California
Volume	1,835,398
Z Score	-6.14

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IBIO pay a dividend?

Capital-return profile for this ticker.

Performance

IBIO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IBIO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+30.0%

Float: +79.1% of shares outstanding

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IBIO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.0

Neutral momentum band

Price vs 200-day MA

+7.9%

50/200-day relationship not available

Beta (5Y)

1.24

More volatile than the market

Sharpe ratio

1.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IBIO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IBIO stock rating?

iBio, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IBIO analysis?

The full report lives at /stocks/IBIO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IBIO?

The latest report frames IBIO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IBIO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.